Obstetrics/Gynecology
RSSArticles
-
New Recommendations Focus on HIV Antiretrovirals
Clinicians involved in preventing and treating HIV will want to update their knowledge base with recommendations from the International Antiviral Society–USA for the use of antiretroviral drugs.
-
Gynecologic Cancers Detected Earlier Because of Affordable Care Act
The diagnosis of gynecologic cancers in young women is occurring at earlier stages because of implementation of the Affordable Care Act, according to results of a recent analysis.
-
Researchers Examine Postmenopausal Bleeding and Endometrial Cancer
To inform clinical decision-making, investigators performed an analysis looking at the frequency of postmenopausal bleeding in endometrial cancers and the risk of endometrial cancer among women who have postmenopausal bleeding.
-
Options Considered for Access to Medication Abortion
As restrictions of clinic access to abortion mount, some women may seek internet access to services. Research indicates that women seeking medication abortion drugs online choose to do so because of barriers to clinic access in states with and without restrictive abortion laws. The choice also can happen when women prefer to self-manage their abortion rather than receive clinical care.
-
Company to Halt U.S. Sales of Essure Device
International pharmaceutical company Bayer has announced that it will cease U.S. sales of its Essure sterilization device as of December 2018. Although the company is halting distribution because of declining sales, the decision comes amid mounting concerns surrounding its use.
-
New Contraceptive Ring Option Receives FDA Approval
Annovera, a soft, reusable, flexible silicone ring containing segesterone acetate and ethinyl estradiol, has been approved by the U.S. Food and Drug Administration.
-
Can Hormone Therapy Prevent the Development of a ‘Dowager’s Hump’?
Postmenopausal hormone therapy may reduce the risk of developing age-related hyperkyphosis, commonly known as a “Dowager’s hump,” and the benefit from hormone therapy use in early menopause may provide long-term benefit.
-
Screening for von Willebrand Disease: Warranted in Young Women With Heavy Menstrual Bleeding
A large, retrospective cohort study using a national claims database revealed that fewer than 20% of young women with heavy menstrual bleeding were screened for von Willebrand disease.
-
A New Treatment for Early Pregnancy Loss
In a recent trial, researchers found that pretreatment with mifepristone followed by treatment with misoprostol resulted in a higher likelihood of successful management of first-trimester pregnancy loss than treatment with misoprostol alone. The rate of surgical evacuation also was reduced in the mifepristone pretreatment arm compared to the misoprostol-alone arm.
-
Marijuana in Pregnancy
A group of investigators posing as pregnant patients called marijuana dispensaries in Colorado to determine whether the stores’ staff recommended it for nausea and vomiting, if there were risks in pregnancy, and if providers should be consulted. The results were enlightening.